Amgen (AMGN) Non-Current Debt (2009 - 2026)

Amgen's Non-Current Debt history runs 18 years deep, the most recent figure standing at $51.9 billion for Q1 2026.

• In Q1 2026, Non-Current Debt fell 3.94% year-over-year to $51.9 billion; the TTM figure through Mar 2026 stood at $51.9 billion (down 3.94% YoY), while the FY2025 annual figure was $50.0 billion, down 11.57% from the prior year.
• Non-Current Debt was $51.9 billion for Q1 2026 at Amgen, up from $50.0 billion in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $63.2 billion in Q4 2023 to a low of $35.7 billion in Q2 2022.
• Historically, Non-Current Debt has averaged $51.8 billion across 5 years, with a median of $54.0 billion in 2025.
• The sharpest annual moves came in 2023 and 2025: Non-Current Debt jumped 69.11% in 2023, then slipped 11.57% in 2025.
• A 5-year view of Non-Current Debt shows it stood at $37.4 billion in 2022, then surged by 69.11% to $63.2 billion in 2023, then slipped by 10.48% to $56.5 billion in 2024, then declined by 11.57% to $50.0 billion in 2025, then advanced by 3.76% to $51.9 billion in 2026.
• The last three Non-Current Debt figures came in at $51.9 billion (Q1 2026), $50.0 billion (Q4 2025), and $52.4 billion (Q3 2025), per Business Quant data.